Clinical Trial Update: Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing high-dose tamoxifen in advanced hormone receptor-high expressed breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2019-10-02